Compare IH & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IH | ORMP |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 117.8M |
| IPO Year | 2020 | N/A |
| Metric | IH | ORMP |
|---|---|---|
| Price | $2.29 | $3.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.8K | ★ 182.4K |
| Earning Date | 12-19-2025 | 11-13-2025 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | 0.29 | ★ 1.03 |
| Revenue | ★ $123,215,612.00 | $2,000,000.00 |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.56 | ★ $2.87 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.55 | $1.82 |
| 52 Week High | $3.60 | $3.20 |
| Indicator | IH | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 70.03 |
| Support Level | $2.15 | $2.83 |
| Resistance Level | $2.40 | $3.03 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 27.42 | 84.48 |
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.